Functional properties of human embryonic stem cell-derived cardiomyocytes: Intracellular Ca2+ handling and the role of sarcoplasmic reticulum in the contraction

Stem Cells

Volumn 24, Issue 2, 2006, Pages 236-245

  Dolnikov, Katya ^a   Shilkrut, Mark ^a,b   Zeevi Levin, Naama ^a   Gerecht Nir, Sharon ^a,b   Amit, Michal ^a,b   Danon, Asaf ^a   Itskovitz Eldor, Joseph ^a,b   Binah, Ofer ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Ca2+ i transients; Contractions; Excitation contraction coupling; Human embryonic stem cell derived cardiomyocytes; Sarcoplasmic reticulum

Indexed keywords

CAFFEINE; CALCIUM; CALSEQUESTRIN; PHOSPHOLAMBAN; RYANODINE; SODIUM CALCIUM EXCHANGE PROTEIN; THAPSIGARGIN; VERAPAMIL;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM CURRENT; CALCIUM TRANSPORT; CELL FUNCTION; CELL ORGANELLE; COMPARATIVE STUDY; CONTROLLED STUDY; EMBRYONIC STEM CELL; EXCITATION CONTRACTION COUPLING; HEART MUSCLE; HEART MUSCLE CELL; HUMAN; HUMAN CELL; MUSCLE CONTRACTION; PROTEIN EXPRESSION; SARCOPLASMIC RETICULUM; WESTERN BLOTTING; ANIMAL; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; EMBRYO; HEART CONTRACTION; HEART MUSCLE CONDUCTION SYSTEM; METABOLISM; MOUSE; PHYSIOLOGY; STEM CELL;

SUIDAE;

ANIMALS; CAFFEINE; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO; HEART CONDUCTION SYSTEM; HUMANS; MICE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; RYANODINE; SARCOPLASMIC RETICULUM; STEM CELLS; THAPSIGARGIN; VERAPAMIL;

EID: 33746890218     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0036     Document Type: Article

References (42)

1. Cohn JN, Bristow MR, Chien KR et al. Report of the National Heart, Lung, and Blood Institute Special Emphasis Panel on Heart Failure Research. Circulation 1997;95:766-770.
2. Hunt SA. Current status of cardiac transplantation. JAMA 1998;280:1692-1698.
3. Nir SG, David R, Zaruba M et al. Human embryonic stem cells for cardiovascular repair. Cardiovasc Res 2003;58:313-323.
4. Dowell JD, Rubart M, Pasumarthi KB et al. Myocyte and myogenic stem cell transplantation in the heart. Cardiovasc Res 2003;58:336-350.
5. Amit M, Itskovitz-Eldor J. Derivation and spontaneous differentiation of human embryonic stem cells. J Anat 2002;200:225-232.
6. Amit M, Carpenter MK, Inokuma MS et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev Biol 2000;227:271-278.
7. Kehat I, Kenyagin-Karsenti D, Snir M et al. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J Clin Invest 2001;108:407-414.
8. Satin J, Kehat I, Caspi O et al. Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes. J Physiol 2004;559:479-496.
9. He JQ, Ma Y, Lee Y et al. Human embryonic stem cells develop into multiple types of cardiac myocytes: Action potential characterization. Circ Res 2003;93:32-39.
10. Mummery C, Ward-van Oostwaard D, Doevendans P et al. Differentiation of human embryonic stem cells to cardiomyocytes: Role of coculture with visceral endoderm-like cells. Circulation 2003;107:2733-2740.
11. Less H, Shilkrut M, Rubinstein I et al. Diseased ventricular myocytes form the pathogenic process of heart failure in murine autoimmune myocarditis. J Autoimmun 1999;12:209-220.
12. Felzen B, Shilkrut M, Less H et al. Fas (CD95/Apo-1)-mediated damage to ventricular myocytes induced by cytotoxic T lymphocytes from perforin-deficient mice: A major role for inositol 1,4,5-trisphosphate. Circ Res 1998;82:438-450.
13. Alpert NR, Leavitt BJ, Ittleman FP et al. A mechanistic analysis of the force-frequency relation in non-failing and progressively failing human myocardium. Basic Res Cardiol 1998;93(suppl 1):23-32.
14. Bers DM. Cardiac excitation-contraction coupling. Nature 2002;415:198-205.
15. Poindexter BJ, Smith JR, Buja LM et al. Calcium signaling mechanisms in dedifferentiated cardiac myocytes: Comparison with neonatal and adult cardiomyocytes. Cell Calcium 2001;30:373-382.
16. Borzak S, Murphy S, Marsh JD. Mechanisms of rate staircase in rat ventricular cells. Am J Physiol 1991;260:H884-H892.
17. Balaguru D, Haddock PS, Puglisi JL et al. Role of the sarcoplasmic reticulum in contraction and relaxation of immature rabbit ventricular myocytes. J Mol Cell Cardiol 1997;29:2747-2757.
18. Beard NA, Laver DR, Dulhunty AF. Calsequestrin and the calcium release channel of skeletal and cardiac muscle. Prog Biophys Mol Biol 2004;85:33-69.
19. Brittsan AG, Kranias EG. Phospholamban and cardiac contractile function. J Mol Cell Cardiol 2000;32:2131-2139.
20. Hassink RJ, Goumans MJ, Mummery CL et al. Human stem cells shape the future of cardiac regeneration research. Int J Cardiol 2004;95:S20-S22.
21. 2+-exchanger on the force-frequency relation. Basic Res Cardiol 1998;93(suppl 1):38-45.
22. Bers DM. Sarcoplasmic reticulum Ca release in intact ventricular myocytes. Front Biosci 2002;7:d1697-d1711.
23. Faggiano P, Colucci WS. The force-frequency relation in normal and failing heart. Cardiologia 1996;41:1155-1164.
24. i transient. J Mol Cell Cardiol 2002;34:941-950.
25. Gwathmey JK, Slawsky MT, Hajjar RJ et al. Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest 1990;85:1599-1613.
26. Mulieri LA, Hasenfuss G, Leavitt B et al. Altered myocardial force-frequency relation in human heart failure. Circulation 1992;85:1743-1750.
27. Pieske B, Kretschmann B, Meyer M et al. Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy. Circulation 1995;92:1169-1178.
28. 2+-ATPase in failing and nonfailing human myocardium. Circ Res 1994;75:434-442.
29. 2+ exchange activity in patients with end-stage heart failure. Cardiovasc Res 1996;31:48-54.
30. Kambayashi M, Miura T, Oh BH et al. Enhancement of the forcefrequency effect on myocardial contractility by adrenergic stimulation in conscious dogs. Circulation 1992;86:572-580.
31. 2+ homeostasis and cardiomyocyte function. J Biol Chem 2000;275:38073-38080.
32. Bers DM. Macromolecular complexes regulating cardiac ryanodine receptor function. J Mol Cell Cardiol 2004;37:417-429.
33. MacLennan DH, Wong PT. Isolation of a calcium-sequestering protein from sarcoplasmic reticulum. Proc Natl Acad Sci U S A 1971;68:1231-1235.
34. Terentyev D, Viatchenko-Karpinski S, Gyorke I et al. Calsequestrin determines the functional size and stability of cardiac intracellular calcium stores: Mechanism for hereditary arrhythmia. Proc Natl Acad Sci U S A 2003;100:11759-11764.
35. Pegg W, Michalak M. Differentiation of sarcoplasmic reticulum during cardiac myogenesis. Am J Physiol 1987;252:H22-H31.
36. Klitzner TS, Friedman WF. A diminished role for the sarcoplasmic reticulum in newborn myocardial contraction: Effects of ryanodine. Pediatr Res 1989;26:98-101.
37. Tanaka H, Shigenobu K. Effect of ryanodine on neonatal and adult rat heart: Developmental increase in sarcoplasmic reticulum function. J Mol Cell Cardiol 1989;21:1305-1313.
38. Klitzner TS. Maturational changes in excitation-contraction coupling in mammaliam myocardium. J Am Coll Cardiol 1991;17:218-225.
39. 2+-release channels in fetal and adult rat hearts. Am J Physiol 1994;269:H778-H782. .
40. 2+ handling in mouse ventricular cells from early embryo to adulthood. Life Sci 2002;71:1279-1292.
41. Moorman AFM, Schumacher CA, de Boer PAJ et al. Presence of functional sarcoplasmic reticulum in the developing heart and its confinement to chamber myocardium. Dev Biol 2000;223:279-290.
42. 2+ oscillations drive spontaneous contractions in cardiomyocytes during early development. Proc Natl Acad Sci U S A 1999;96:8259-8264.